NCT04637152View on ClinicalTrials.gov

Sacubitril/Valsartan in Resistant Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

July 22, 2022

Study Completion Date

August 17, 2022

Conditions
Resistant HypertensionBlood Pressure
Interventions
DRUG

Sacubitril-Valsartan

Use of sacubitril/valsartan after suspension of ACE inhibitors or ARBs.

Trial Locations (2)

40301-110

General Hospital Roberto Santos, Salvador

40301-155

Hospital Universitário Professor Edgard Santos, Salvador

All Listed Sponsors
collaborator

Hospital Universitário Professor Edgard Santos

OTHER

lead

Hospital Geral Roberto Santos

OTHER

NCT04637152 - Sacubitril/Valsartan in Resistant Hypertension | Biotech Hunter | Biotech Hunter